Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Article type: Research Article
Authors: Alegret, Montserrata; * | Cuberas-Borrós, Gemmab; c | Vinyes-Junqué, Georginaa | Espinosa, Anaa | Valero, Sergia; d | Hernández, Isabela | Roca, Isabelb; c | Ruíz, Agustína | Rosende-Roca, Maitéea | Mauleón, Anaa | Becker, James T.e; f; g | Castell-Conesa, Joanb; c | Tárraga, Lluísa | Boada, Mercèa; c
Affiliations: [a] Memory Clinic of Fundació ACE, Institut Català de Neurociències Aplicades, Barcelona, Spain | [b] Nuclear Medicine Department, Hospital Universitari Vall d'Hebron, Barcelona, Spain | [c] Hospital Universitari Vall d'Hebron-Institut de Recerca, Universitat Autònoma de Barcelona (VHIR-UAB), Barcelona, Spain | [d] Psychiatry Department, Hospital Universitari Vall d'Hebron, CIBERSAM, Universitat Autònoma de Barcelona, Barcelona, Spain | [e] Department of Neurology, University of Pittsburgh, Pittsburgh, PA, USA | [f] Department of Psychiatry, University of Pittsburgh, Pittsburgh, PA, USA | [g] Department of Psychology, University of Pittsburgh, Pittsburgh, PA, USA
Correspondence: [*] Correspondence to: Montserrat Alegret, PhD, Memory Clinic of Fundació ACE, Institut Català de Neurociències Aplicades, C/Marquès de Sentmenat, 35-37, 08014 Barcelona, Spain. Tel.: +34 93 4304720; Fax: +34 93 4193542; E-mail: [email protected].
Abstract: The 15-Objects Test (15-OT) provides useful gradation of visuoperceptual impairment from normal aging through Alzheimer's disease (AD) and correlates with temporo-parietal perfusion. The objectives of this study were to analyze progression of 15-OT performance in mild cognitive impairment (MCI) and AD, and its correlates with cognition and single photon emission computerized tomography (SPECT), as well as to examine neuropsychological and SPECT differences between the MCI patients who developed AD and those who did not. From the initial 126 participants (42/group), 38 AD, 39 MCI, and 38 elderly controls (EC) were reassessed (SPECT: 35 AD, 33 MCI, 35 EC) after two years. The progression of cognitive and SPECT scores during this period was compared between groups, and baseline data between converters and non-converters. The 15-OT was the only measure of progression that differed between the three groups; worsening scores on 15-OT were associated with worsening in verbal and visual retention, and decreased perfusion on left postsubicular area. In the MCI patients, cerebral perfusion fell over the two years in medial-posterior cingulate and fronto-temporo-parietal regions; AD showed extensive changes involving almost all cerebral regions. No SPECT changes were detected in controls. At baseline, the MCI patients who developed AD differed from non-converters in verbal recognition memory, but not in SPECT perfusion. In conclusion, SPECT and 15-OT appear to provide a potential measure to differentiate between normal aging, MCI, and AD. Worsening on 15-OT was related to decreased perfusion in postsubicular area; but further longitudinal studies are needed to determine the contribution of 15-OT as a predictor of AD from MCI.
Keywords: 15-objects test, Alzheimer's disease, brain SPECT, cerebral perfusion, longitudinal, mild cognitive impairment, prospective, two-year follow-up, visuoperception
DOI: 10.3233/JAD-2012-111850
Journal: Journal of Alzheimer's Disease, vol. 30, no. 1, pp. 109-120, 2012
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
[email protected]
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office [email protected]
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
如果您在出版方面需要帮助或有任何建, 件至: [email protected]